Best Life Sciences Companies in Lombardy, Italy
The 116 best Life Sciences companies in Lombardy, Italy in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: NMS Group.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Lombardy
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NMS Group Developer of therapeutics for the treatment of cancer | $158M | 53 mo ago | 1 | Nancy Selling Founder | WordPressMySQLPHP+21 | Top 50M | — | — |
| 2 | AAVantgarde Bio Developer of gene therapies for inherited retinal disorders | $65M | 36 mo ago | 4 | Alberto Auricchio Co-Founder | — | — | — | — |
| 3 | Newron Pharmaceuticals Therapies for patients with diseases of the central nervous system and pain | $55M | 83 mo ago | 23 | — | DrupalPHPBootstrap+19 | Top 5M | 2 patents Synthesis of substituted phenethylamine alkaneamide pharmaceutical intermediates | 1 award |
| 4 | Genenta Science Developer of lentivirus-based gene and cell therapies for cancer | $34M | 15 mo ago | 9 | Pierluigi Paracchi Co-Founder Chairman And Chief Executive Officer | DrupalPHPAmazon Web Services+29 | Top 10M | — | — |
| 5 | EryDel Developer of an erythrocyte encapsulation drug delivery system 19Funding top 44%Market bottom 36%Global bottom 36%News bottom 18% All 4 signals ▾Fundingtop 44% Marketbottom 36% Globalbottom 36% Newsbottom 18% Funding: Raised $31.7M across 2 rounds · 2 rounds over 13 yrs (0.2/yr) Market: 25 employees rank vs industry peers · Fliar Intelligence Index 19/100 | $32M | 97 mo ago | 25 | — | — | — | — | — |
| 6 | WISE Provider of solutions for neuromodulation and neuromonitoring | $30M | 45 mo ago | 40 | — | — | — | 61 patents Patents concentrated in health & consumer products | — |
| 7 | Altheia Science Developer of stem cell-based therapeutics for cancer and autoimmune diseases | $19M | 92 mo ago | 5 | — | WordPressMySQLPHP+29 | Top 50M | 15 patents Targeted immunotherapy and diagnostics for myeloid cancers using novel tumor-specific antigens | — |
| 8 | General Medical Merate Manufacture X-ray diagnostics equipments | $16M | 167 mo ago | 300 | — | WordPressMySQLPHP+24 | Top 5M | 41 patents Advanced radiology imaging hardware: collimators and predictive control systems for X‑ray devices. | — |
| 9 | Tethis Provider of automated solutions for in liquid biopsy 53Patents top 26%Growth top 28%Innovation top 29%Funding top 40% All 8 signals ▾Patentstop 26% Growthtop 28% Innovationtop 29% Fundingtop 40% Moattop 45% Globalbottom 42% Techbottom 38% Marketbottom 35% Patents: 57 patents matched (strict assignee match) · 16 filings since 2022 vs 11 in 2017-21 Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $16M | 17 mo ago | 32 | — | WordPressMySQLPHP+18 | Top 10M | 57 patents Sample preparation and immobilization technologies for analytical and diagnostic bioassays | — |
| 10 | Newronika Developer of devices for neurodegenerative diseases | $11M | 16 mo ago | 16 | Alberto Priori Founder & President | WebflowCloudflare TurnstileHSTS+10 | Top 50M | 58 patents Adaptive deep brain stimulation devices for personalized neurological disease therapy | 2 job openings |
| 11 | KLISBio Developer of regenerative implantable products by using silk fibroins | $9M | 122 mo ago | — | Antonio Alessandrino Co-Founder | RubyErlangTailwind CSS+12 | Top 50M | 3 patents Biomimetic peptide therapeutics for bone regeneration and tissue engineering | 1 award |
| 12 | ComfTech Provider of smart garments for physiological monitoring | $8M | 94 mo ago | 10 | — | WordPressMySQLPHP+19 | Top 10M | 26 patents Sensor‑integrated garments for continuous vital‑sign monitoring, especially neonatal respiration | — |
| 13 | Dianax Developer of a diagnostic test cartridge | $5M | 94 mo ago | 5 | — | — | — | 19 patents Microfluidic lab-on-a-chip platforms for sample concentration, purification, and biomarker detection. | — |
| 14 | Tissuelab Human osteotendinous tissues for reconstructive musculoskeletal surgery | $4M | 226 mo ago | 3 | — | — | — | 7 patents Human bone paste for grafting and bone tissue regeneration applications | — |
| 15 | I-VASC Provider of a minimally invasive device for the treatment of varicose veins | $4M | 49 mo ago | 5 | Mario Salerno Founder & Chairman | — | — | 28 patents Patents concentrated in health & consumer products | — |
| 16 | T-ONE Therapeutics Developer of therapeutics for cancer treatment | $2M | 45 mo ago | — | Beatrice Bodega Founder | — | — | — | — |
| 17 | enGenome Bioinformatics products and software for personalized medicine | $2M | 50 mo ago | 18 | Ivan Limongelli Co-Founder & CTO | PleskNode.jsElement UI+22 | Top 10M | 10 patents Computational prediction of pathogenicity for digenic and oligogenic genomic variants | — |
| 18 | Thereson Therapeutic Magnetic Resonance based device with applications in wound care and orthopaedics | $1M | 145 mo ago | 5 | Michela Cocchi Bianchi Chief Executive Officer and Founder | — | — | 7 patents Medical devices delivering pulsed resonant electromagnetic therapy for tissue treatment | — |
| 19 | Plasmore Develops nanoplasmon imaging technology | $1M | 65 mo ago | — | Andrea Valsesia Co-Founder | — | — | 4 patents Patents concentrated in chemistry & materials | — |
| 20 | BiomimX Provider of organs-on-chip platforms for preclinical studies | $697K | 44 mo ago | 9 | Marco Rasponi Co-Founder | WordPressMySQLPHP+16 | Top 50M | 3 patents Microfluidic platforms for electrophysiological measurement and stimulation | — |
| 21 | Holifya Provider of DNA test kits for personalized health recommendations | $535K | 40 mo ago | 7 | Marco Brustia Co-Founder | WordPress Block EditorWordPressMySQL+28 | Top 5M | — | — |
| 22 | Margherita Inventions Finger guard to protect from accident puntures | $350K | 164 mo ago | — | Carlo Giuberchio Founder & CEO | — | — | — | — |
| 23 | Nerviano Medical Sciences Italian, clinical-stage oncology-focused drug discovery company | $198K | 97 mo ago | 400 | Luciano Baielli CEO & Director | WordPressPleskMySQL+18 | Top 10M | 1,294 patents Small-molecule kinase inhibitors and antibody‑drug conjugate payloads for cancer therapy | — |
Top 12 Life Sciences companies in Lombardy
#1
Public · Milan, Lombardy · founded 2014 · 9 employees$33.6Mraised▾
Developer of lentivirus-based gene and cell therapies for cancer. The lead candidateTemferon is a lentivirus-based hematopoietic stem progenitor cell immuno-gene therapy for Glioblastoma, solid tumor, and hematological malignancies. Also, has Tie2-Expressing Monocytes immunotherapies for multiple cancer treatment.
- Mar 2025Post IPO$21.9M
- Sep 2019Series C$14.6M
- Sep 2017Series B$8M
- Mar 2015Series A$11M
#2
Series A · Milan, Lombardy · founded 2004 · 32 employees$15.8Mraised▾
Provider of automated solutions for in liquid biopsy. It offer a pre‑analytical workstation for blood samples at the collection siteand separates plasma and stabilizes cellular fraction directly on nanocoated SmartBioSurface microscope slides ideal for detecting circulating tumor cells (CTCs) and preserving cell-free plasma.
- Jan 2025PE$15.3M
- Aug 2018Grant (prize money)$58.4K
- May 2018Grant (prize money)$60K
- Jun 2016Grant (prize money)$340.2K
#3
Series B · Cologno Monzese, Lombardy · founded 2016 · 16 employees$11.1Mraised▾
Newronika has developed a medical device for neurodegenerative diseases. The company has developed a product called AlphaDBS which is a closed-loop deep brain neuromodulation system used to interpret the bioelectrical neuronal activity. The company has also developed another product known as WebBioBank which is a web-based platform used by the researchers to collect, analyze, and interpret biosignals including also electronic health records data for patients going through neuromodulation treatment.
#4
Series A · Milan, Lombardy · founded 2021 · 4 employees$65.3Mraised▾
Developer of gene therapies for inherited retinal disorders. The company is developing Adeno-Associated Viral (AAV) vectors for the delivery of large genes to the tissue and cells targeting genetic blindness.
- Jun 2023Series A$65.3M
- Jun 2021Seed—
#5
Acquired · Nerviano, Lombardy · founded 1965 · 1 employees$157.6Mraised▾
Developer of therapeutics for the treatment of cancer. The company develops innovative new chemical entities (NCE) for the treatment of cancers and its lead product is an oral inhibitor of IDH1 and IDH2, for solid tumors. Also, it develops Entrectinib, the kinase inhibitor drug as an antitumor therapy.
#6
Series C · Milan, Lombardy · founded 2011 · 40 employees$29.6Mraised▾
WISE is a provider of solutions for neuromodulation and neuromonitoring. It has developed minimally invasive, biocompatible, foldable, and stretchable implantable leads for neuromodulation and neuromonitoring. The foldable nature of their electrodes and wires enables them to be implanted into the area of interest such as spine through a minimally invasive surgery. It provides a flexible electrode that can be folded and introduced into the spinal column using a catheter, thereby allowing it to be used to treat back pain and others. It also provides solutions for mapping of brain activity and pre-surgical epilepsy monitoring. Wise produces their electrodes through a proprietary process called supersonic cluster beam implantation (SCBI) technology, whereby nanoparticles of platinum and iridium are embedded into a silicon-based substrate, creating a composite layer below the surface that becomes an electro-conductive skin.
- Aug 2022Grant (prize money)$50.1K
- Oct 2020Series C$17.6M
- Aug 2019Grant (prize money)$55.1K
- May 2017Series B$7.3M
#7
Public · Milan, Lombardy · founded 1999 · 23 employees$54.9Mraised▾
Therapies for patients with diseases of the central nervous system and pain. It has a pipeline of drug candidates which include Xadago (safinamide) for the treatment of Parkinson’s disease, Evenamide (NW-3509) for the treatment of patients with positive symptoms of schizophrenia, Sarizotan for patients with Rett syndrome, and ralfinamide for patients with specific rare pain indications.
#8
Acquired · Milan, Lombardy · founded 2007 · 25 employees$31.7Mraised▾
Developer of an erythrocyte encapsulation drug delivery system. The company has developed the proprietary red cell loader (RCL) non-invasive device and erykit that helps in loading on human red blood cells with small molecules such as protein and enzymes. The company has multiple therapeutics in the pipeline such as erdex is in the 3rd stage of clinical trials and eetm has completed the 2nd phase of the clinical trial.
- Apr 2018Series B$31.7M
- Jan 2016Grant (prize money)$4.7M
- Jul 2013Series B—
- Series A—
#9
Series A · Milan, Lombardy · founded 2011 · 5 employees$3.9Mraised▾
Provider of a minimally invasive device for the treatment of varicose veins. The company offers treatment of varicose veins using its propriety technology - sclerotherapy technique catheter and three balloons for sclerotherapy. The catheter is inserted, the vein is isolated and blood is replaced, then the drug is released and absorbed for recovery.
- May 2022Series A$1.8M
- 2021Seed$1.2M
- 2021Seed$849.5K
#10
Seed · Milan, Lombardy · founded 2022$2.5Mraised▾
Developer of therapeutics for cancer treatment. It offers anticancer therapies that are focused on the regulation of the activation of T lymphocytes to a sequence of human DNA to kill cancer cells.
- Sep 2022Seed$2.5M
#11
Series A · Milan, Lombardy · founded 2017 · 5 employees$19.3Mraised▾
Developer of stem cell-based therapeutics for cancer and autoimmune diseases. The drugs provide the expression of programmed death-ligand 1 (PD-L1) at molecular and protein levels by lentiviral vector-based engineering of patients’ hematopoietic stem cells used for the treatment of type 1 diabetes and multiple sclerosis. The company's lead product candidates used against these two diseases are in pre-clinical trials.
- Sep 2018Series A$19.3M
#12
Series A · Bresso, Lombardy · founded 2013$8.6Mraised▾
Developer of regenerative implantable products by using silk fibroins. The company leverages a silk-based technology platform to develop scaffold materials for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears, and situations where a sustained drug release is needed.
- Apr 2016Series A$7.9M
- Jul 2015Grant (prize money)$55.2K
- 2015Seed$538K
- 2015Grant (prize money)$55K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.